SVA [SINOVAC BIOTECH] 6-K: Sinovac Biotech Submits Clinical Trial Application to SFDA

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2011-04-18
Original SEC Filing: Click here


Webplus: SVA/20110418/6-K/2_EX-99.1/000.htm SEC Original: v218786_ex99-1.htm
Sinovac Biotech Submits Clinical Trial Application to SFDA for Pneumococcal Conjugate Vaccine (PCV) -Completes Pre-Clinical Studies- Source: Sinovac Biotech Ltd. On Thursday March 3, 2011, 8:00 am EST BEIJING, March 3, 2011 /PRNewswire-Asia/ — Sinovac Biotech Ltd. (Nasdaq:SVA – News), a leading provider of biopharmaceutical products in China, announced today it submitted the application to commence clinical trials for its




Webplus: SVA/20110418/6-K/1/000.htm SEC Original: v218786_6k.htm
SINOVAC BIOTECH LTD. No. 39 Shangdi Xi Road Haidian District Beijing 100085, People’s Republic of China x o Form 20-F SINOVAC BIOTECH LTD.



Company Information:

Ticker: SVA, Company: SINOVAC BIOTECH LTD, Type: 6-K, Date: 2011-04-18CIK: 0001084201, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
39 SHANGDI XI ROAD
BEIJING 100085

Home Page Forums

By | 2016-03-24T02:08:04+00:00 April 18th, 2011|Categories: Chinese Stocks, SVA, Webplus ver|Tags: , , , , , |0 Comments

About the Author:

Leave A Comment

Skip to toolbar